Soufflé Therapeutics
Watertown
About Soufflé Therapeutics
Soufflé Therapeutics is a biotechnology company specializing in the development of nucleic acid medicines designed for precise delivery and targeting of disease-causing cells. The company's mission is to create potent, precise, and safe medicines that can be tailored for a broad range of diseases by leveraging breakthroughs in genetic medicine and drug delivery technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $200.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: souffletx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/souffl-therapeutics-33670 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.